Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
4553 | 1767 | 40.8 | 86% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY | 1353914 |
99 | 3 | HEPATITIS C VIRUS//HEPATITIS C//HEPATITIS B VIRUS | 74452 |
26 | 2 | HEPATITIS C VIRUS//HEPATITIS C//HCV | 34145 |
4553 | 1 | NS5B POLYMERASE//NS5B//HCV NS5B POLYMERASE | 1767 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | NS5B POLYMERASE | authKW | 1053804 | 4% | 85% | 72 |
2 | NS5B | authKW | 687497 | 4% | 52% | 77 |
3 | HCV NS5B POLYMERASE | authKW | 605236 | 2% | 97% | 36 |
4 | NS3 PROTEASE | authKW | 592646 | 3% | 70% | 49 |
5 | HCV | authKW | 287375 | 15% | 6% | 261 |
6 | NS3 | authKW | 259228 | 3% | 31% | 49 |
7 | NS3 HELICASE | authKW | 238930 | 1% | 63% | 22 |
8 | NS3 4A PROTEASE | authKW | 208060 | 1% | 71% | 17 |
9 | NON NUCLEOSIDE INHIBITORS | authKW | 175044 | 2% | 35% | 29 |
10 | ANTIVIRAL THER Y | address | 173254 | 1% | 53% | 19 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Chemistry, Medicinal | 19849 | 32% | 0% | 557 |
2 | Virology | 10743 | 19% | 0% | 336 |
3 | Chemistry, Organic | 3644 | 22% | 0% | 380 |
4 | Biochemistry & Molecular Biology | 1479 | 27% | 0% | 477 |
5 | Pharmacology & Pharmacy | 1177 | 17% | 0% | 303 |
6 | Gastroenterology & Hepatology | 304 | 5% | 0% | 84 |
7 | Microbiology | 232 | 6% | 0% | 110 |
8 | Biophysics | 202 | 5% | 0% | 88 |
9 | Biochemical Research Methods | 178 | 4% | 0% | 76 |
10 | Infectious Diseases | 82 | 3% | 0% | 50 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ANTIVIRAL THER Y | 173254 | 1% | 53% | 19 |
2 | METAB VIRAL DIS EXCELLENCE DRUG DISCOVERY | 88851 | 1% | 43% | 12 |
3 | MRL ROME | 76966 | 0% | 64% | 7 |
4 | IST RIC BIOL MOL P ANGELETTI SPA | 69117 | 0% | 100% | 4 |
5 | IRBM | 66349 | 1% | 30% | 13 |
6 | MED CHEM ORGAN PHARMACEUT CHEM | 56545 | 0% | 55% | 6 |
7 | METAB ANTIVIRAL DIS EXCELLENCE DRUG DISCOVE | 51838 | 0% | 100% | 3 |
8 | R4CQ | 51838 | 0% | 100% | 3 |
9 | VIROL DISCOVERY BIOL | 51838 | 0% | 100% | 3 |
10 | ANTIVIRAL | 35047 | 2% | 6% | 32 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 40175 | 14% | 1% | 242 |
2 | JOURNAL OF MEDICINAL CHEMISTRY | 9279 | 6% | 1% | 108 |
3 | ANTIVIRAL RESEARCH | 8739 | 2% | 1% | 42 |
4 | JOURNAL OF VIROLOGY | 5428 | 6% | 0% | 113 |
5 | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 4806 | 5% | 0% | 82 |
6 | BIOORGANIC & MEDICINAL CHEMISTRY | 3385 | 3% | 0% | 51 |
7 | ACS MEDICINAL CHEMISTRY LETTERS | 2441 | 1% | 1% | 14 |
8 | ANTIVIRAL THERAPY | 2334 | 1% | 1% | 16 |
9 | JOURNAL OF VIRAL HEPATITIS | 1734 | 1% | 1% | 15 |
10 | ANNUAL REPORTS IN MEDICINAL CHEMISTRY | 1557 | 1% | 1% | 9 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | NS5B POLYMERASE | 1053804 | 4% | 85% | 72 | Search NS5B+POLYMERASE | Search NS5B+POLYMERASE |
2 | NS5B | 687497 | 4% | 52% | 77 | Search NS5B | Search NS5B |
3 | HCV NS5B POLYMERASE | 605236 | 2% | 97% | 36 | Search HCV+NS5B+POLYMERASE | Search HCV+NS5B+POLYMERASE |
4 | NS3 PROTEASE | 592646 | 3% | 70% | 49 | Search NS3+PROTEASE | Search NS3+PROTEASE |
5 | HCV | 287375 | 15% | 6% | 261 | Search HCV | Search HCV |
6 | NS3 | 259228 | 3% | 31% | 49 | Search NS3 | Search NS3 |
7 | NS3 HELICASE | 238930 | 1% | 63% | 22 | Search NS3+HELICASE | Search NS3+HELICASE |
8 | NS3 4A PROTEASE | 208060 | 1% | 71% | 17 | Search NS3+4A+PROTEASE | Search NS3+4A+PROTEASE |
9 | NON NUCLEOSIDE INHIBITORS | 175044 | 2% | 35% | 29 | Search NON+NUCLEOSIDE+INHIBITORS | Search NON+NUCLEOSIDE+INHIBITORS |
10 | RNA DEPENDENT RNA POLYMERASE | 168477 | 3% | 16% | 60 | Search RNA+DEPENDENT+RNA+POLYMERASE | Search RNA+DEPENDENT+RNA+POLYMERASE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SOFIA, MJ , CHANG, WS , FURMAN, PA , MOSLEY, RT , ROSS, BS , (2012) NUCLEOSIDE, NUCLEOTIDE, AND NON-NUCLEOSIDE INHIBITORS OF HEPATITIS C VIRUS NS5B RNA-DEPENDENT RNA-POLYMERASE.JOURNAL OF MEDICINAL CHEMISTRY. VOL. 55. ISSUE 6. P. 2481-2531 | 176 | 54% | 112 |
2 | GEMMA, S , BROGI, S , NOVELLINO, E , CAMPIANI, G , MAGA, G , BRINDISI, M , BUTINI, S , (2014) HCV-TARGETED ANTIVIRALS: CURRENT STATUS AND FUTURE CHALLENGES.CURRENT PHARMACEUTICAL DESIGN. VOL. 20. ISSUE 21. P. 3445 -3464 | 169 | 68% | 3 |
3 | HAUDECOEUR, R , PEUCHMAUR, M , AHMED-BELKACEM, A , PAWLOTSKY, JM , BOUMENDJEL, A , (2013) STRUCTURE-ACTIVITY RELATIONSHIPS IN THE DEVELOPMENT OF ALLOSTERIC HEPATITIS C VIRUS RNA-DEPENDENT RNA POLYMERASE INHIBITORS: TEN YEARS OF RESEARCH.MEDICINAL RESEARCH REVIEWS. VOL. 33. ISSUE 5. P. 934-984 | 109 | 95% | 19 |
4 | DE FRANCESCO, R , CARFI, A , (2007) ADVANCES IN THE DEVELOPMENT OF NEW THERAPEUTIC AGENTS TARGETING THE NS34A SERINE PROTEASE OR THE NS5B RNA-DEPENDENT RNA POLYMERASE OF THE HEPATITIS C VIRUS.ADVANCED DRUG DELIVERY REVIEWS. VOL. 59. ISSUE 12. P. 1242-1262 | 99 | 86% | 89 |
5 | KOCH, U , NARJES, F , (2007) RECENT PROGRESS IN THE DEVELOPMENT OF INHIBITORS OF THE HEPATITIS C VIRUS RNA-DEPENDENT RNA POLYMERASE.CURRENT TOPICS IN MEDICINAL CHEMISTRY. VOL. 7. ISSUE 13. P. 1302 -1329 | 97 | 76% | 78 |
6 | ZAPF, CW , BLOOM, JD , LEVIN, JI , (2007) RECENT PROGRESS ON NOVEL HCV INHIBITORS.ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 42. VOL. 42. ISSUE . P. 281-300 | 94 | 80% | 9 |
7 | DAS, D , HONG, J , CHEN, SH , WANG, GY , BEIGELMAN, L , SEIWERT, SD , BUCKMAN, BO , (2011) RECENT ADVANCES IN DRUG DISCOVERY OF BENZOTHIADIAZINE AND RELATED ANALOGS AS HCV NS5B POLYMERASE INHIBITORS.BIOORGANIC & MEDICINAL CHEMISTRY. VOL. 19. ISSUE 16. P. 4690 -4703 | 86 | 75% | 11 |
8 | LI, H , SHI, ST , (2010) NON-NUCLEOSIDE INHIBITORS OF HEPATITIS C VIRUS POLYMERASE: CURRENT PROGRESS AND FUTURE CHALLENGES.FUTURE MEDICINAL CHEMISTRY. VOL. 2. ISSUE 1. P. 121 -141 | 69 | 93% | 20 |
9 | WATKINS, WJ , RAY, AS , CHONG, LS , (2010) HCV NS5B POLYMERASE INHIBITORS.CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT. VOL. 13. ISSUE 4. P. 441-465 | 68 | 83% | 36 |
10 | ZHAO, C , WANG, YH , MA, ST , (2015) RECENT ADVANCES ON THE SYNTHESIS OF HEPATITIS C VIRUS NS5B RNA-DEPENDENT RNA-POLYMERASE INHIBITORS.EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY. VOL. 102. ISSUE . P. 188 -214 | 72 | 76% | 1 |
Classes with closest relation at Level 1 |